Computer tool for multiple sclerosis treatment decisions
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at how a computer tool helps doctors make treatment decisions for people with relapsing-remitting multiple sclerosis. It uses your MRI and treatment history to see if the tool improves care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have relapsing-remitting multiple sclerosis (RRMS).
- You are thinking about changing your MS treatment, either because you're not tolerating it well, or because you've had recent disease activity.
- You have had an MRI within the last 6 months that includes special brain scans.
- You have not taken certain strong MS medications (like natalizumab, ocrelizumab, or alemtuzumab) recently.
- You don't have other autoimmune diseases, and you're not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
This trial tests whether treating relapsing multiple sclerosis (RRMS) aggressively and early with a specific medication can slow disease progression. You may qualify if you were recently diagnosed, have had recent disease activity, and are willing to take a strong immunosuppressive drug with regular MRI monitoring.
This study looks at whether MS relapses happen without any signs of new disease activity on an MRI scan. By tracking your symptoms and scans, researchers hope to better understand how MS affects people in real life. If you qualify, you may help improve future treatment decisions.
This study uses artificial intelligence to help doctors better manage MS care. It uses MRI scans and a phone app to track your condition over time.
This study follows adults with relapsing-remitting multiple sclerosis using MRI scans and blood tests. It aims to understand how the disease behaves and what markers in blood and imaging may relate to changes over time.
This study collects health information and samples from people with multiple sclerosis (MS) in different stages to help develop better tools for managing the disease. By participating, you could help researchers use data science to improve MS care.
Hear when a new Relapsing - Remitting Multiple Sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.